glp 1 new drug study shows popular GLP-1 weight loss may slow biological aging Study: Most Patients Can Safely
Description
The study found that there was a statistically significant weight and visceral fat reduction in the group receiving the dose of 15mg/day after 4 weeks of the intervention (4)
Norwood, J
How did this drug category get kicked off through the lens of Eli Lilly
Canadian Press health coverage receives support through a partnership with the Canadian Medical Association
10.1056/NEJMoa2206038 [DOI] [PubMed] [Google Scholar] 42
In a large trial with a median follow-up of 3.8 years, liraglutide (1.78 mg) significantly reduced cardiovascular risk factors such as weight, systolic, and diastolic blood pressure
